Raphas Co. Ltd Asset Resilience Ratio

Latest as of June 2026: 5.58%

Raphas Co. Ltd asset resilience ratio. Raphas Co. Ltd (214260) has an Asset Resilience Ratio of 5.58% as of June 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Raphas Co. Ltd defensive interval ratio to measure how many days the company can operate on defensive assets alone.

Liquid Assets

₩3.79 Billion

≈ $2.57 Million USD Cash + Short-term Investments

Total Assets

₩67.97 Billion

≈ $46.06 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio of Raphas Co. Ltd (2017–2025)

Asset resilience ratio of Raphas Co. Ltd from 2017 to 2025. This chart shows how Raphas Co. Ltd's Asset Resilience Ratio has changed over time. Read 214260 total liabilities for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down Raphas Co. Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see balance sheet size of Raphas Co. Ltd.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	₩0.00	0%
Short-term Investments	₩3.79 Billion	5.58%
Total Liquid Assets	₩3.79 Billion	5.58%

Asset Resilience Insights

Limited Liquidity: Raphas Co. Ltd maintains only 5.58% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Raphas Co. Ltd Industry Peers by Asset Resilience Ratio

Compare Raphas Co. Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Madrigal Pharmaceuticals Inc NASDAQ:MDGL	Biotechnology	62.31%
Verona Pharma plc F:I9SA	Biotechnology	0.00%
Centessa Pharmaceuticals PLC ADR NASDAQ:CNTA	Biotechnology	33.37%
Shanghai RAAS Blood Products Co Ltd Class A SHE:002252	Biotechnology	2.03%
Beijing Tiantan Biological Products Corp Ltd SHG:600161	Biotechnology	8.08%
Bavarian Nordic CO:BAVA	Biotechnology	10.83%
Hebei Changshan Biochem Pharma SHE:300255	Biotechnology	-0.03%
Tibet Cheezheng Tibetan Medicine Co Ltd SHE:002287	Biotechnology	37.31%

Raphas Co. Ltd Asset Resilience Ratio by Year (2017–2025)

Raphas Co. Ltd asset resilience ratio by year from 2017 to 2025. The table below shows the annual Asset Resilience Ratio data for Raphas Co. Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	13.15%	₩9.88 Billion ≈ $6.69 Million	₩75.08 Billion ≈ $50.88 Million	+3.49pp
2024-12-31	9.66%	₩7.35 Billion ≈ $4.98 Million	₩76.09 Billion ≈ $51.57 Million	-12.02pp
2023-12-31	21.69%	₩21.78 Billion ≈ $14.76 Million	₩100.40 Billion ≈ $68.04 Million	-11.09pp
2022-12-31	32.78%	₩31.49 Billion ≈ $21.34 Million	₩96.06 Billion ≈ $65.10 Million	-13.44pp
2021-12-31	46.22%	₩45.22 Billion ≈ $30.65 Million	₩97.84 Billion ≈ $66.31 Million	+22.39pp
2020-12-31	23.83%	₩14.25 Billion ≈ $9.66 Million	₩59.83 Billion ≈ $40.54 Million	-2.48pp
2019-12-31	26.30%	₩16.54 Billion ≈ $11.21 Million	₩62.88 Billion ≈ $42.62 Million	+12.85pp
2018-12-31	13.45%	₩4.64 Billion ≈ $3.15 Million	₩34.51 Billion ≈ $23.39 Million	-15.59pp
2017-12-31	29.04%	₩10.11 Billion ≈ $6.85 Million	₩34.81 Billion ≈ $23.59 Million	--

pp = percentage points

About Raphas Co. Ltd

KQ:214260 Korea Biotechnology

Market Cap

$40.34 Million

₩59.53 Billion KRW

Market Cap Rank

#22489 Global

#1449 in Korea

Share Price

₩7080.00

Change (1 day)

+0.57%

52-Week Range

₩6720.00 - ₩15190.00

All Time High

₩75400.00